In human studies, patients with bipolar disorder showed higher binding of VMAT2 (Zubieta et al., 2001), patients with major depression also showed elevated VMAT2 density (Zucker et al., 2002) and structural change of VMAT2 (Zalsman et al., 2011) in platelets. This evidence concerns the gene SLC18A2 and major depressive disorder.